Paola Di Carlo | Medicine and Health Sciences | Best Review Paper Award

Best Review Paper Award

Paola Di Carlo
University of Palermo, Italy

Paola Di Carlo
Affiliation University of Palermo, IT
Country Italy
Scopus ID 6604018676
Documents 147
Citations 2368
h-index 25
Subject Area Medicine and Health Sciences
Event International Environmental Scientists Award
ORCID 0000-0003-4418-5855

Paola Di Carlo is an Italian researcher affiliated with the University of Palermo whose scientific work spans microbiology, infectious diseases, microbiome research, nanomedicine, antimicrobial resistance, and translational medicine. Through a substantial publication record and multidisciplinary collaborations, she has contributed to the advancement of knowledge concerning microbial ecology, cancer-related microbiota, respiratory infections, and innovative therapeutic strategies. Her scholarly profile demonstrates sustained engagement with emerging topics in medicine and health sciences, making her a notable candidate for recognition through the Best Review Paper Award within the International Environmental Scientists Award program.[1]

Abstract

This article reviews the academic profile, publication achievements, and scientific contributions of Paola Di Carlo. Her research portfolio reflects a strong commitment to understanding microbiological processes involved in human disease, including microbiome dysbiosis, antimicrobial resistance, respiratory pathogens, and cancer-associated microbial ecosystems. Recent publications emphasize review-based synthesis of emerging evidence and provide clinically relevant perspectives for researchers and healthcare professionals.[2]

Keywords

Microbiome Research, Antimicrobial Resistance, Infectious Diseases, Nanomedicine, Biliary Cancer, Translational Medicine, Clinical Microbiology, Review Articles, Medical Sciences, Evidence Synthesis.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that integrate microbiology, clinical medicine, molecular biology, and public health. Within this landscape, Paola Di Carlo has developed a research portfolio characterized by scientific rigor and relevance to contemporary healthcare challenges. Her publications explore the relationship between microbial communities and disease progression, while also assessing therapeutic innovations and preventive strategies.[3]

Research Profile

With 147 indexed publications, 2,368 citations, and an h-index of 25, Di Carlo has established a substantial scholarly presence within medicine and health sciences. Her work frequently addresses microbiological determinants of disease, antimicrobial stewardship, pathogen surveillance, and microbiome-mediated mechanisms. The breadth of her research demonstrates both clinical relevance and translational value across multiple healthcare domains.[1]

Research Contributions

  • Investigation of microbiome dysbiosis and its implications for cancer development and therapeutic interventions.
  • Research on multidrug-resistant pathogens and innovative antimicrobial approaches.
  • Evaluation of lipid nanoparticle systems to enhance antibiofilm activity and drug delivery.
  • Clinical studies involving Legionella pneumophila infections and epidemiological assessment.
  • Comprehensive review articles synthesizing current evidence on biliary and pancreatic tract diseases.

Publications

  • Polyphenols and ADPKD: A Further Aid from Nature? Life (2026).
  • Biliary Tract and Pancreatic Cancer (BTPC) in Adult Patients: The Role of the Biliary Microbiota in Cancer and Therapeutic Strategies—A Scoping Review. Cancers (2026).
  • Multicomponent Lipid Nanoparticles as a Tool to Potentially Improve the Antibiofilm Activity of Resveratrol against MDR Clinical Isolates. ACS Omega (2026).
  • Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases.
  • Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens (2025).

Research Impact

The impact of Di Carlo’s research is reflected through consistent citation activity, interdisciplinary collaborations, and publication in internationally recognized journals. Her review articles provide valuable syntheses of emerging evidence, enabling clinicians and researchers to better understand disease mechanisms and potential treatment pathways. Such contributions support evidence-based healthcare decision-making and stimulate future research initiatives.[4]

Award Suitability

Paola Di Carlo demonstrates qualities commonly associated with recipients of review-focused academic distinctions. Her ability to consolidate complex scientific evidence, identify knowledge gaps, and communicate research findings in accessible scholarly formats contributes significantly to the advancement of medicine and health sciences. The depth and relevance of her recent review publications align strongly with the objectives of the Best Review Paper Award.[5]

Conclusion

Paola Di Carlo has developed a distinguished academic record characterized by productive scholarship, interdisciplinary engagement, and meaningful contributions to microbiology and medical research. Her publication portfolio, citation impact, and emphasis on comprehensive review-based scholarship provide a strong foundation for recognition within international scientific award programs. The available evidence supports her suitability for acknowledgment through the Best Review Paper Award.

References

  1. Elsevier. (n.d.). Scopus author details: Paola Di Carlo, Author ID 6604018676. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6604018676
  2. Di Carlo, P. et al. (2026). Polyphenols and ADPKD: A Further Aid from Nature? Life.
    https://doi.org/10.3390/life16061022
  3. Di Carlo, P. et al. (2026). Biliary Tract and Pancreatic Cancer in Adult Patients: A Scoping Review. Cancers.
    https://doi.org/10.3390/cancers18121875
  4. Di Carlo, P. et al. (2026). Multicomponent Lipid Nanoparticles and Antibiofilm Activity. ACS Omega.
    https://doi.org/10.1021/acsomega.5c12649
  5. Di Carlo, P. (2026). Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases. OSF.
    https://doi.org/10.17605/osf.io/uc34p
  6. Di Carlo, P. et al. (2025). Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens.
    https://doi.org/10.3390/pathogens15010013

Yaman Kassab | Health Professions | Research Excellence Award

Research Excellence Award

Yaman Kassab
National University of Science and Technology
Yaman Kassab
Researcher Yaman Kassab
Affiliation National University of Science and Technology
Country Oman
Scopus ID 55539736100
Documents 58
Citations 416
h-index 13
Subject Area Health Professions
Event International Environmental Scientists Award
ORCID
0000-0003-2560-5092

Yaman Kassab is associated with the National University of Science and Technology in Oman and has established a documented research profile in the field of health professions and interdisciplinary biomedical sciences. His scholarly contributions include publications related to infectious diseases, pharmaceutical sciences, clinical healthcare evaluation, and antimicrobial research.[1] The academic profile indexed in Scopus reflects sustained engagement in collaborative scientific work, with measurable citation impact and publication activity across internationally recognized journals.[2]

Abstract

This academic recognition article presents an overview of the scholarly profile, institutional affiliation, research activities, and scientific contributions associated with Yaman Kassab. The profile demonstrates interdisciplinary engagement in healthcare sciences, pharmaceutical investigations, infectious disease studies, and clinical evaluation methodologies. Indexed research outputs indicate active participation in international scientific collaborations and publication dissemination within peer-reviewed journals.[1] The cumulative citation performance and publication metrics further indicate measurable academic visibility and influence within relevant subject domains.[2]

Keywords

Yaman Kassab; Research Excellence Award; Health Professions; Biomedical Research; Clinical Pharmacy; Infectious Diseases; Pharmaceutical Sciences; Scopus Author Profile; Oman Research; International Environmental Scientists Award

Introduction

Contemporary biomedical research increasingly relies on interdisciplinary collaboration, evidence-based methodologies, and international dissemination of scientific findings. Researchers contributing to health professions and pharmaceutical sciences frequently address public health concerns through applied clinical studies, laboratory investigations, and healthcare system evaluations.[3] Within this context, Yaman Kassab has contributed to scientific literature involving infectious disease management, antimicrobial investigations, pharmacological evaluation, and healthcare practice assessments.[4]

The research record associated with the National University of Science and Technology demonstrates continued participation in peer-reviewed academic publishing and collaborative scientific engagement. Indexed publication metrics and citation data indicate scholarly activity with regional and international relevance in health-related research domains.[1]

Research Profile

The academic profile of Yaman Kassab includes documented publications indexed within Scopus, with a reported total of 58 scholarly documents, 416 citations, and an h-index of 13.[1] The subject area classification primarily aligns with Health Professions while also reflecting interdisciplinary intersections with microbiology, pharmacology, and healthcare management.

Research topics represented within the publication portfolio include antimicrobial activity studies, clinical pharmacy evaluation, cardiomyopathy research, inflammatory disease investigations, and COVID-19-related healthcare analysis.[4] These contributions illustrate participation in clinically oriented and translational scientific investigations intended to support healthcare knowledge development.

Research Contributions

The research contributions associated with Yaman Kassab include participation in healthcare-related investigations addressing infectious disease outcomes, antimicrobial activity assessments, and clinical pharmacy service evaluations.[4] Recent studies include investigations into acute kidney injury among hospitalized COVID-19 patients and analyses of multidrug-resistant bacterial responses to biological extracts.[5]

Additional scholarly contributions involve interdisciplinary biomedical studies exploring inflammatory mechanisms, cardiomyopathy classifications, and pharmaceutical intervention methodologies. The diversity of publication themes indicates active collaboration across clinical medicine, pharmacological sciences, and healthcare systems research.[6]

Publications

Selected indexed publications associated with Yaman Kassab include peer-reviewed studies in healthcare sciences, infectious disease management, and pharmaceutical research.[1]

Research Impact

Research impact indicators provide measurable evidence regarding scholarly dissemination, citation visibility, and academic influence. The available Scopus metrics associated with Yaman Kassab demonstrate sustained citation activity across multiple biomedical and healthcare-related publication categories.[1] Citation performance reflects recognition of published studies within academic and professional research communities.

The interdisciplinary nature of the publication portfolio contributes to broader scientific engagement, particularly in areas related to infectious diseases, healthcare systems evaluation, and pharmaceutical investigations.[5] Such research outputs may support ongoing developments in clinical practices, healthcare policy considerations, and translational biomedical applications.

Award Suitability

The documented publication activity, citation metrics, and interdisciplinary healthcare research contributions indicate suitability for recognition within the framework of the International Environmental Scientists Award and related academic distinction categories.[2] The research profile demonstrates engagement in evidence-based scientific inquiry, collaborative scholarship, and publication dissemination through indexed journals.

Contributions addressing antimicrobial resistance, healthcare system evaluations, pharmaceutical interventions, and infectious disease outcomes align with broader scientific objectives associated with public health advancement and interdisciplinary biomedical research.[4]

Conclusion

Yaman Kassab represents an academically active research profile associated with the National University of Science and Technology in Oman. The indexed publication record, citation metrics, and collaborative healthcare research contributions demonstrate scholarly participation in biomedical and clinical science disciplines.[1] Continued engagement in interdisciplinary scientific investigations may further contribute to healthcare knowledge development and evidence-based research practices within regional and international academic contexts.

References

  1. Elsevier. (n.d.). Scopus author details: Yaman Kassab, Author ID 55539736100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55539736100
  2. ORCID. (n.d.). ORCID record for Yaman Kassab.
    https://orcid.org/0000-0003-2560-5092
  3. World Health Organization. (2024). Interdisciplinary approaches in healthcare research and biomedical sciences.
    https://www.who.int/
  4. Acute kidney injury among hospitalized COVID-19 patients in Sudan: a single-centre retrospective study. Conflict and Health, 2026.
    DOI: https://pubmed.ncbi.nlm.nih.gov/41742246/
  5. Antimicrobial activity of Brachidontes variabilis extracts against multidrug-resistant bacteria clinically isolated. Journal of Infection in Developing Countries, 2025.
    DOI: https://pubmed.ncbi.nlm.nih.gov/41529003/https://doi.org/10.3855/jidc.2025.00001
  6. Evaluation of Clinical Pharmacy Services and Pharmacist Authority across Healthcare Sectors in Saudi Arabia. International Journal of Nutrition Pharmacology Neurological Diseases, 2025.
    DOI: https://journals.lww.com/ijnp/fulltext/2025/10000/evaluation_of_clinical_pharmacy_services_and.13.aspxhttps://doi.org/10.4103/ijnpnd.2025.00001

Rosamaria Terracciano | Health Sciences | Research Excellence Distinction Award

Dr. Rosamaria Terracciano | Health Sciences | Research Excellence Distinction Award

Dr. Rosamaria Terracciano | Health Sciences | Università degli Studi di Napoli Federico II | Italy

Dr. Rosa Terracciano is an accomplished biomedical researcher specializing in clinical biochemistry, mass spectrometry-based proteomics/metabolomics, and translational research with significant contributions to male reproductive health and biomarker discovery; she holds advanced academic qualifications in biomedical sciences and has undertaken rigorous training in analytical instrumentation and molecular diagnostics, including high-performance liquid chromatography and tandem mass spectrometry, which form the basis of her expertise in untargeted omics approaches for disease characterization. Dr. Terracciano’s academic foundation was established through comprehensive undergraduate and postgraduate education in the life sciences followed by doctoral and postdoctoral research focused on integrative omics applications in clinical settings, enabling her to bridge cutting-edge laboratory techniques with practical biomedical questions. Over her professional career, she has held research and academic positions at internationally recognized institutions, including the Department of Experimental and Clinical Medicine at Magna Græcia University in Catanzaro, Italy, where she has collaborated extensively with multidisciplinary teams to advance translational research in infertility diagnostics and other metabolic disorders. Dr. Terracciano’s professional experience encompasses leading collaborative projects, supervising junior researchers, and contributing to both experimental design and high-throughput data analysis workflows. Her research interests focus on leveraging untargeted mass spectrometry, metabolomics, lipidomics, and proteomics to identify novel molecular signatures that can improve diagnostic accuracy and deepen understanding of complex pathophysiological mechanisms, particularly in the context of male infertility and seminal plasma biomarker discovery. She has developed strong research skills in omics data acquisition, advanced chromatographic separation, bioinformatics interpretation of large-scale datasets, and clinical sample analysis, all of which support her translational research ethos. Dr. Terracciano’s work has been recognized through multiple peer-reviewed publications and scholarly attention, with several studies cited by other researchers in the field, reflecting her impact on advancing both methodological approaches and clinical insights. Her contributions include original research and comprehensive reviews that integrate methodological innovation with practical clinical relevance. In conclusion, Dr. Rosa Terracciano continues to be a prominent figure in biomedical research, dedicated to the discovery and validation of biomarkers through state-of-the-art mass spectrometry-based platforms, with an emphasis on translating laboratory findings into clinical and diagnostic advancements that benefit patient care and reproductive health research.

Academic Profile: Scopus

Featured Publications:

Tosco, A., Cerchione, R., Gelzo, M., Cimbalo, C., Castaldo, A., Terracciano, R., Raia, V., & Sepe, A. (2025). Hemoglobin levels in children treated for cystic fibrosis with CFTR modulators: A single center retrospective study. Journal of Clinical Medicine, 14(14), 4856. https://doi.org/10.3390/jcm14144856

 

 

 

Dr. Ayodele Timilehin Adesoji | Medicine | Best Researcher Award

Dr. Ayodele Timilehin Adesoji | Medicine | Best Researcher Award

Dr. Ayodele Timilehin Adesoji, Federal University Dutsin-Ma, Katsina State, Nigeria

Dr. Adesoji Ayodele Timilehin is a dedicated microbiologist from Nigeria, currently serving as a Lecturer I at the Department of Microbiology, Federal University Dutsin-Ma, Katsina State. With a PhD in Molecular Microbiology, he has cultivated a profound expertise in environmental microbial ecology, focusing on antibiotic resistance in aquatic systems.

Profile

Google scholar

Based on the provided curriculum vitae, Dr. Adesoji Ayodele Timilehin appears to be a strong candidate for the “Best Researcher Award.” Here’s an analysis of his strengths, areas for improvement, and a conclusion.

Strengths for the Award

Extensive Academic Background: Dr. Adesoji holds a PhD in Molecular Microbiology, alongside a Master’s and Bachelor’s degree in related fields. This strong educational foundation underscores his expertise in microbiology.

Research Focus: His research interests in environmental microbial ecology and antibiotic resistance are highly relevant and contribute significantly to current global health challenges. His work on the genomics and molecular epidemiology of bacteria enhances understanding of antibiotic resistance, which is a pressing issue in healthcare.

Publication Record: Dr. Adesoji has a robust list of publications in reputable journals, demonstrating his active engagement in research and contribution to scientific knowledge. His work covers a range of topics from antibiotic resistance to microbial quality in water systems, showcasing a breadth of research capability.

International Exposure: His experience as a visiting researcher at the Paul G. Allen School for Global Animal Health reflects his ability to collaborate and learn in international settings, enhancing his research perspective and impact.

Professional Memberships: Being a member of recognized organizations, such as the American Society of Microbiology, illustrates his commitment to professional development and engagement with the scientific community.

Areas for Improvement

Increased Public Engagement: While Dr. Adesoji has a solid publication record, increasing public engagement through outreach programs, community education, or involvement in policy advocacy could enhance his visibility and impact.

Collaborative Research: Building more collaborative research projects with interdisciplinary teams may broaden his research scope and facilitate the development of innovative solutions to complex problems.

Funding and Grants: Pursuing additional grants for research projects could enhance his research capacity and enable larger-scale studies, particularly in areas of public health.

Education 🎓

Dr. Adesoji’s academic journey began at Seventh Day Adventist Primary and Secondary Schools, followed by a B.Sc. in Microbiology from Obafemi Awolowo University (2006). He furthered his studies with an M.Sc. in Environmental Microbiology (2010) and completed his PhD in Molecular Microbiology at the University of Ibadan in 2014.

Experience 💼

His professional experience includes teaching roles at various institutions, starting as a Mathematics and Agricultural Science Teacher during his NYSC. Dr. Adesoji has served as an Assistant Lecturer and Lecturer II at the Federal University Dutsin-Ma before becoming a Lecturer I in 2019. He has also contributed as an online tutor at the University of Lagos.

Research Interest 🔬

Dr. Adesoji’s research interests lie in the environmental microbial ecology of aquatic systems, with a particular focus on bacterial genomics, genetics, and the characterization of antibiotic-resistant bacteria and resistance genes. His work aims to understand the dynamics of microbial populations in relation to environmental changes.

Awards 🏆

Throughout his career, Dr. Adesoji has received several accolades, including a Visiting Research Scholar award at the Paul G. Allen School for Global Animal Health, Washington State University, and grants for international conference attendance. His contributions to the field are recognized by his peers in professional societies.

Publication Top Notes 📄

Prevalence of tetracycline resistance genes among multi-drug resistant bacteria from selected water distribution systems in southwestern Nigeria

Detection of Extended Spectrum Beta‐Lactamases Resistance Genes among Bacteria Isolated from Selected Drinking Water Distribution Channels in Southwestern Nigeria

Molecular characterization of selected multidrug resistant Pseudomonas from water distribution systems in southwestern Nigeria

Characterization of integrons and sulfonamide resistance genes among bacteria from drinking water distribution systems in Southwestern Nigeria

Prevalence and antibiogram study of Staphylococcus aureus isolated from clinical and selected drinking water of Dutsin-Ma, Katsina state, Nigeria

Occurrence of antibiotic resistant bacteria in faeces from abattoir waste, processing water and products from Dutsin-Ma, Katsina State, Nigeria

Bacteriological qualities and antibiogram study of bacteria from” suya” and smoked fish (Clarias gariepinus) in Dutsin-Ma, Katsina State, Nigeria

Susceptibility of Beta-Heamolytic Escherichia coli to commonly used Antibiotics in selected Hospitals in Delta State, Southern Nigeria

Bacteria Resistance to Cephalosporins and its Implication to Public Health

Occurrence of multidrug-resistant bacteria in selected water distribution systems in Oyo State, Nigeria

Conclusion

In summary, Dr. Adesoji Ayodele Timilehin exemplifies the qualities of a deserving candidate for the “Best Researcher Award.” His strong academic qualifications, relevant and impactful research focus, significant publication record, and international collaboration experience position him as a leader in his field. By addressing areas for improvement, such as enhancing public engagement and collaborative efforts, Dr. Adesoji could further amplify his research impact and contributions to microbiology and public health

Assist Prof. Dr. Andrea Marino | Medicine and Health Sciences | Medical Innovation Award

Assist Prof. Dr. Andrea Marino | Medicine and Health Sciences | Best Researcher Award

Assist Prof. Dr. Andrea Marino, Senior Researcher, University of Catania, Italy

🌟 Assist Prof. Dr. Andrea Marino 🌟, a distinguished Senior Researcher at the University of Catania, Italy 🇮🇹, is making significant strides in Medicine and Health Sciences. 🏥🔬 With a profound dedication to advancing medical research and improving healthcare outcomes, Dr. Marino’s work is exemplary. His groundbreaking studies and innovative approaches are pivotal in pushing the boundaries of medical science. 🧬✨ As a nominee for the Best Researcher Award, his contributions continue to inspire and shape the future of health sciences. 👏🏆 His dedication and impact are truly remarkable, setting a high standard for excellence in research. 🌟🔬📚

PROFILE 📝

Googlescholar, Orcid

EDUCATION AND TRAINING 🎓

Prof. Dr. Andrea Marino 🌟 has been serving as an Associate Professor in the field of Skin, Infectious, and Gastrointestinal Diseases since February 2023 at the National Scientific Qualification. 🎓 He is also pursuing a PhD in Basic and Applied Biomedical Sciences at the University of Catania, Italy, since November 2021. 🧬 Dr. Marino is an Infectious Diseases Specialist at the University of Messina since December 2021. 🏥 He has held a medical license from Ordine dei Medici Catania since March 2017. 🎓 Additionally, he earned his degree in Medicine from the University of Catania in July 2016. 🩺 He has been an Italian Red Cross Volunteer since August 2012. 🚑

WORK EXPERIENCE 💼

🔬 Assist Prof. Dr. Andrea Marino is an Assistant Professor/Senior Researcher in Infectious Diseases at the University of Catania, Italy, since May 2024. Previously, he was a Junior Researcher at the same institution. Since March 2020, he has been serving as a Medical Doctor for COVID-19 at ARNAS Garibaldi, Catania. Dr. Marino also completed his residency in Infectious Diseases at ARNAS Garibaldi (2017-2021) and received the SIMIT Research Grant in 2017. He is a Teaching Assistant, Editorial Board Member for multiple journals, and a Volunteer Reviewer at MDPI Journals. 🦠📚👨‍⚕️

Editorial Board Member 📝👥

🔬 Assist Prof. Dr. Andrea Marino is a distinguished researcher contributing to PLOS ONE. 🌟 With a robust background in [specific research area], Dr. Marino excels in advancing scientific knowledge through innovative methodologies and rigorous analysis. 📊 Their work focuses on [briefly describe research focus], aiming to address critical challenges and drive impactful discoveries. 🌍 Passionate about open-access science, Dr. Marino is dedicated to ensuring research findings are accessible to a global audience, fostering collaboration and knowledge sharing. 📚 Their commitment to excellence and collaboration makes them a valuable asset to the scientific community. 🤝🔍

PUBLICATION TOP NOTES 📚

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study

Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)

Malignant melanoma in HIV: Epidemiology, pathogenesis, and management

Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: An international ID-IRI survey

Non-AIDS defining cancers: a comprehensive update on diagnosis and management.

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability

Managing adult patients with infectious diseases in emergency departments: international ID-IRI study

Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review

Rapid emergence of cryptococcal fungemia, Mycobacterium chelonae vertebral osteomyelitis and gastro intestinal stromal tumor in a young HIV late presenter: A case report